According to an order issued by the Judicial Panel for Multidistrict Litigation the lawsuits which claims that diabetes medications Invokana and Invokamet cause ketoacidosis, kidney damage, and other injuries were transferred to New Jersey District Court for consolidation. According to the court document the order was issued on 7th December, as per the order all the lawsuits from districts in Georgia, Illinois, Kentucky, Missouri, Louisiana, Minnesota, Virginia and West Virginia are consolidated to the New Jersey District Court before U.S. District Judge Brian R. Martinotti. Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, are facing hundreds of Invokana lawsuits due to serious injury caused by Invokana. In all the lawsuits the allegations are similar. The plaintiff’s claims that manufacturers failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious and life threatening medical complications associated with these drug.
Although Invokana was approved by the United States Food and Drug Administration at the end of March in 2013 it associated with several life threatening complications, the FDA has issued a follow-up side effect warning in May of this year to inform patients and doctors about the health risks linked with Invokana medication. The complications include Diabetic Ketoacidosis or Acidosis, Kidney Failure or Kidney Complications, Heart Attack or Stroke, Urinary Tract Infections, Bone Fractures and Blood Infection. According to the agency they have revised the warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk. The FDA advised the doctors to carefully consider the factors that may affect patients to the kidney problems before prescribing the drugs. The FDA suggested patients not to stop or change their diabetes medicines without first talking to their health care professional.
The Multidistrict Litigation of lawsuits will speed the process of handling complex cases, such as air disaster litigation or complex product liability suits. It makes the case easier and time saving for the lawyers as multidistrict litigation centralizes similar cases for pretrial proceedings. Plaintiffs claimed in their consolidation request that the drug’s manufacturer did nothing, rather than warn the public, Janssen Pharmaceuticals, a subsidiary of corporate giant Johnson & Johnson, actively defended its product and failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious and life threatening medical complications associated with these drugs.
The FDA has taken measures to warn patients. But Invokana still remains in the market. The agency has to take action to protect consumers from dangerous medicines and ban these life threatening drugs from the market. If you or someone you love who was prescribed Invokana and then suffered from ketoacidosis, kidney failure, Heart Attack or Stroke may be eligible to file a personal injury lawsuit against the drug’s manufacturer. The Drugsclaim Lawyers and Attorneys are investigating claims that Invokana may be linked to kidney failure, cardiovascular complications and bone fractures. In filing personal injury lawsuits, injured patients seek compensation for medical expenses, lost work and pain and suffering, among other damages.